1) Asten J,
Cuijpers V,
Hulsbergen-van de Kaa C,
et al.
High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies. Magn Reson Mater Phy. 2008;21:435–42.
2)Bathen TF,
Geurts B,
Sitter B,
Fjøsne HE,
Lundgren S,
Buydens LM,
Gribbestad IS,
Postma G,
Giskeødegård GF.
Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery. PLoS One.
2013 Apr 17;8(4):e61578.
doi: 10.1371/journal.pone.0061578.
3)Bathen TF,
Jensen LR,
Sitter B,
Fjösne HE,
Halgunset J,
Axelson DE,
Gribbestad IS,
Lundgren S.
MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread,
grade,
and hormone status. Breast Cancer Res Treat.
2007 Aug;104(2):181-9.
4) Bolan P.J.,
Nelson M.T.,3,
Yee D.
and Garwood M. Imaging in breast cancer: Magnetic resonance spectroscopy. Breast Cancer Research 2005,
7:149-152 (DOI 10.1186/bcr1202)
5)Borgan E,
Lindholm EM,
Moestue S,
Mælandsmo GM,
Lingjærde OC,
Gribbestad IS,
Børresen-Dale AL,
Engebraaten O,
Sørlie T.
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts. Mol Oncol.
2013 Feb;7(1):130-42.
6)Borgan E,
Sitter B,
Lingjærde OC,
Johnsen H,
Lundgren S,
Bathen TF,
Sørlie T,
Børresen-Dale AL,
Gribbestad IS.
Merging transcriptomics and metabolomics--advances in breast cancer profiling. BMC Cancer.
2010 Nov 16;10:628.
7) Cecil KM,
Schnall MD,
Siegelman ES,
Lenkinski RE.
The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001,
68:45-54.
8)Comet Batlle J,
Vilanova JC,
Barceló Obregón J,
Maroto Genover A, Osorio Fernández M,
López Bonet E,
Torrent Quer N,
Ordis Dalmau M,
Barceló Vidal C.
Diagnóstico del cáncer de próstata mediante espectroscopía de Resonancia Magnética endorectal. Arch.
Esp.
Urol.,
59,
10 (953-963),
2006
9)Elkhaled A,
Jalbert L,
Constantin A,
Yoshihara HA,
Phillips JJ,
Molinaro AM,
Chang SM,
Nelson SJ.
Characterization of metabolites in infiltrating gliomas using ex vivo 1 H high-resolution magic angle spinning spectroscopy.NMR Biomed.
2014 Mar 5
10)Giskeødegård GF,
Lundgren S,
Sitter B,
Fjøsne HE,
Postma G,
Buydens LM,
Gribbestad IS,
Bathen TF.
Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers. NMR Biomed.
2012 Nov;25(11):1271-9.
11)Grinde MT,
Skrbo N,
Moestue SA,
Rødland EA,
Borgan E,
Kristian A,
Sitter B,
Bathen TF,
Børresen-Dale AL,
Mælandsmo GM,
Engebraaten O,
Sørlie T,
Marangoni E,
Gribbestad IS.
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Res.
2014 Jan 21;16(1):R5.
12) Martinez-Bisbal,
M.
C.,
Monleon,
D.,
Assemat,
O.,
Piotto,
M.,
Piquer,
J.,
Llacer,
J.
L.,
and Celda,
B.
(2009) Determination of metabolite concentrations in human brain tumour biopsy samples using HR-MAS and ERETIC measurements.
NMR in biomedicine 22,
199-206
13)Jagannathan NR,
Kumar M,
Seenu V,
Coshic O,
Dwivedi SN,
Julka PK,
Srivastava A,
Rath GK.
Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001,
84:1016-1022.
14)Kvistad KA,
Bakken IJ,
Gribbestad IS,
Ehrnholm B,
Lundgren S,
Fjosne HE,
Haraldseth O.
Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spec- troscopy. J Magn Reson Imaging 1999,
10:159-164.
15)Moestue SA,
Borgan E,
Huuse EM,
Lindholm EM,
Sitter B,
Børresen-Dale AL,
Engebraaten O,
Maelandsmo GM,
Gribbestad IS.
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
BMC Cancer.
2010 Aug 17;10:433.
16)Gonzalez-Darder J,
Talamantes F,Cortés O,Gil-Benson R,López-Gines C,
Cerdá-Nicolás M,Celda B. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. J.
Proteome Res.,
2008,
7 (7),
pp 2882–2888
17)Righi V,
Roda JM,
Paz J,
Mucci A Tugnoli V,
Rodriguez-Tarduchi G,Barrios L,Schenetti L,
García-Martín ML.1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas.
NMR Biomed.
2009 Jul;22(6):629-37.
18)Sitter B,
Lundgren S,
Bathen TF,
Halgunset J,
Fjosne HE,
Gribbestad IS.Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.NMR Biomed.
2006 Feb;19(1):30-40.
19) Soaresa D.P.,
Lawb M.
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clinical Radiology (2009) 64,
12e21
20)Stenman K.,
P.är Stattin,
Stenlund H.,
Riklund K,
Gröbner G,
Bergh A.1H HRMAS NMR Derived Bio-markers Related to Tumor Grade,
Tumor Cell Fraction,
and Cell Proliferation
in Prostate Tissue Samples.
Biomarker Insights 2011:6 39–47